CN110240605B - 青蒿素二聚物的制备方法 - Google Patents
青蒿素二聚物的制备方法 Download PDFInfo
- Publication number
- CN110240605B CN110240605B CN201810191390.3A CN201810191390A CN110240605B CN 110240605 B CN110240605 B CN 110240605B CN 201810191390 A CN201810191390 A CN 201810191390A CN 110240605 B CN110240605 B CN 110240605B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- acid
- coupling
- coupling reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical class C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 238000005859 coupling reaction Methods 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 8
- 230000008878 coupling Effects 0.000 claims abstract description 7
- 238000010168 coupling process Methods 0.000 claims abstract description 7
- 125000006239 protecting group Chemical group 0.000 claims abstract description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- -1 benzyloxycarbonyl (Cbz) Chemical class 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical group FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 238000010511 deprotection reaction Methods 0.000 claims description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 5
- 229910052736 halogen Chemical group 0.000 abstract description 4
- 150000002367 halogens Chemical group 0.000 abstract description 4
- 125000004185 ester group Chemical group 0.000 abstract description 3
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- BJDCWCLMFKKGEE-ISOSDAIHSA-N artenimol Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-ISOSDAIHSA-N 0.000 description 4
- 229960002521 artenimol Drugs 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 229930016266 dihydroartemisinin Natural products 0.000 description 4
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical group CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- QCMILQCFDHNPGB-UHFFFAOYSA-N benzyl n,n-bis(2-hydroxyethyl)carbamate Chemical compound OCCN(CCO)C(=O)OCC1=CC=CC=C1 QCMILQCFDHNPGB-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical group C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 150000000138 dihydroartemisinin derivatives Chemical class 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- OCAAZRFBJBEVPS-UHFFFAOYSA-N prop-2-enyl carbamate Chemical group NC(=O)OCC=C OCAAZRFBJBEVPS-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- DFNJPPOAVCXQQQ-UHFFFAOYSA-N (1,1,1-trichloro-2-methylpropan-2-yl) carbamate Chemical group ClC(Cl)(Cl)C(C)(C)OC(N)=O DFNJPPOAVCXQQQ-UHFFFAOYSA-N 0.000 description 1
- LZZRHUUMSXNYBI-UHFFFAOYSA-N (2,4-dichlorophenyl)methyl carbamate Chemical group NC(=O)OCC1=CC=C(Cl)C=C1Cl LZZRHUUMSXNYBI-UHFFFAOYSA-N 0.000 description 1
- SDEOSHAQCMPJIJ-UHFFFAOYSA-N (4-methoxyphenyl)methyl carbamate Chemical group COC1=CC=C(COC(N)=O)C=C1 SDEOSHAQCMPJIJ-UHFFFAOYSA-N 0.000 description 1
- FPBOSUGVPBRYCA-UHFFFAOYSA-N (4-nitrophenyl)methyl carbamate Chemical group NC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 FPBOSUGVPBRYCA-UHFFFAOYSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- FJANNOJSTOGZHK-UHFFFAOYSA-N 1-adamantyl carbamate Chemical compound C1C(C2)CC3CC2CC1(OC(=O)N)C3 FJANNOJSTOGZHK-UHFFFAOYSA-N 0.000 description 1
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- XGMDYIYCKWMWLY-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonic acid Chemical compound OS(=O)(=O)CC(F)(F)F XGMDYIYCKWMWLY-UHFFFAOYSA-N 0.000 description 1
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- LIJLYNWYKULUHA-UHFFFAOYSA-N 2-chloroethyl carbamate Chemical group NC(=O)OCCCl LIJLYNWYKULUHA-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- FAHZIKXYYRGSHF-UHFFFAOYSA-N 3-bromo-4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1Br FAHZIKXYYRGSHF-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical group C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZZOKVYOCRSMTSS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl carbamate Chemical group C1=CC=C2C(COC(=O)N)C3=CC=CC=C3C2=C1 ZZOKVYOCRSMTSS-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical group NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical group CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- KLKFAASOGCDTDT-UHFFFAOYSA-N ethoxymethoxyethane Chemical compound CCOCOCC KLKFAASOGCDTDT-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000007517 lewis acids Chemical group 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- RMIODHQZRUFFFF-UHFFFAOYSA-M methoxyacetate Chemical group COCC([O-])=O RMIODHQZRUFFFF-UHFFFAOYSA-M 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- 125000005547 pivalate group Chemical group 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical group CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- LVLANIHJQRZTPY-UHFFFAOYSA-N vinyl carbamate Chemical group NC(=O)OC=C LVLANIHJQRZTPY-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及青蒿素二聚物制备方法:化合物(I)与化合物(II)在偶联试剂的作用下于溶剂中发生偶联反应得到化合物(III)。其中,P为H或N的保护基,R为羟基、酯基、磺酸酯基或卤素。本发明的制备方法具有原料易得,立体选择性好,操作安全简单,产品纯度高,成本低等优点。
Description
技术领域
本发明涉及药物化学领域,具体涉及青蒿素二聚物SM1044的制备方法,SM1044可用于疟疾、病毒、肿瘤等疾病的治疗。
背景技术
青蒿素二聚物SM1044除了具有抗疟活性外,还可用于病毒、肿瘤等疾病的治疗。
专利CN102153564公开了其制备方法(制备方法一)。该方法以二氢青蒿素为原料,在三氟化硼乙醚催化条件下与乙二醇反应,经过柱层析分离得到化合物中间体V。中间体V与对甲苯磺酰氯反应得到化合物VI,进一步的与氨水反应直接得到化合物SM1044。但是由于此化合物反应主要得到VII,而化合物SM1044只是合成化合物VII时的副产物。专利CN102153564也公开了制备方法(制备方法二),该方法以VI为原料,通过制备化合物VII后,再与化合物VI反应制备SM1044。上述两种方法路线较长,且收率低,使用操作繁琐的柱层析进行纯化,不利于工业生产。
因此,寻找原材料价廉易得,操作安全简单,产品纯度高,低成本的适于工业化生产的制备青蒿素二聚物的新方法,对加快相关新药的研究进程,降低相关新药的生产成本具有重要意义。
发明内容
本发明所要解决的技术问题是克服现有技术的不足,提供青蒿素二聚物制备的新方法。本发明提供了一种制备青蒿素二聚物的新方法,所述方法为:
其中,P为H或N的保护基;R为羟基、酯基、磺酸酯基或卤素;
化合物(I)与化合物(II)于溶剂中在偶联试剂的作用下发生偶联反应得到化合物(III);
其中,所述N的保护基为氨基甲酸甲酯基、氨基甲酸乙酯基、取代的氨基甲酸乙酯基、氨基甲酸2-三甲硅基乙酯基、氨基甲酸2-氯乙酯基、氨基甲酸1,1-二甲基-2-卤乙酯基、氨基甲酸1,1-二甲基-2,2,2-三氯乙酯基、氨基甲酸1-甲基-1-(4-联苯基)乙酯基、氨基甲酸叔丁酯基(Boc)、氨基甲酸乙烯基酯基、氨基甲酸烯丙基酯基、氨基甲酸苄酯基(Cbz)、氨基甲酸对甲氧基苄酯基、氨基甲酸对硝基苄酯基、氨基甲酸2,4-二氯苄酯基、氨基甲酸2-二苯基异丙基酯基、氨基甲酸9-芴基甲酯基(Fmoc)、氨基甲酸1-金刚烷酯基、氨基甲酸烯丙基酯基、甲酰胺基、乙酰胺基、三氯乙酰胺基、三氟乙酰胺基。所述取代的氨基甲酸乙酯中的取代是指被选自卤素、C1-C3的烷基、苯基等中的一种或多种取代基所取代。
所述偶联试剂选自路易斯酸,路易斯碱。
所述溶剂选自二氯甲烷、二氯乙烷、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲亚砜、环丁砜、N-甲基吡咯烷酮、甲苯、二甲苯、氯苯、四氢呋喃、甲基四氢呋喃、乙二醇二甲醚、二乙二醇二甲醚、甲基叔丁基醚、二乙氧基甲烷、二甲氧基甲烷、乙腈、苯腈、正己烷、正庚烷、环己烷中的一种或多种;
所述偶联试剂的用量相对于化合物(I)为0.0001~5摩尔当量,更优选为0.001~1摩尔当量;
所述偶联反应的温度不限,优选为0℃~100℃,更优选为0~50℃;
所述偶联反应的时间优选为0.5~24小时,更优选1~12小时;
所述偶联反应可在任何压力下进行,通常在常压下反应。
当P为N的保护基时,所述产物(化合物(III))经进一步脱保护反应得到青蒿素二聚物SM1044。
所述脱保护反应在有机酸、有机碱、无机酸或无机碱存在下进行。
所述有机酸选自甲酸、乙酸、丙酸、丁酸、辛酸、己二酸、乙二酸、丙二酸、丁二酸、马来酸、酒石酸、苯甲酸、苯乙酸、邻苯二甲酸、对苯二甲酸、戊酸、己酸、癸酸、硬脂酸、软脂酸、丙烯酸、酒石酸、草酸、苹果酸、苯甲酸、三氟醋酸、甲磺酸、乙磺酸、对甲苯磺酸;所述有机碱选自吡啶、哌啶、吗啉、二环己胺、对二甲氨基吡啶、三乙胺、三(2-氨乙基)胺、四丁基氟化铵、二异丙基乙基胺、氨水、甲胺、乙胺、二乙胺、三乙烯二胺、叔丁醇钾、叔丁醇钠、硼氢化钠、三乙基硼氢化钠、硼氢化钾、三乙基硼氢化钾、硼氢化锂、三乙基硼氢化锂;所述无机酸选自硫酸、盐酸、硝酸;所述无机碱选自碳酸钾、碳酸铯、氢氧化钾、氢氧化钠、氢氧化锂。
所述偶联反应的反应产物(SM1044)还可以进一步在结晶溶剂中通过结晶得到固体形态的化合物(SM1044)。
所述结晶溶剂选自正戊烷,正己烷,正庚烷,正辛烷,环己烷,石油醚,甲苯,氯苯,甲醇,乙醇,异丙醇,正丁醇中的一种或多种。
所述结晶温度为-10℃~100℃,优选为-10℃~50℃,更优选为0℃~20℃。
采用本发明方法制备得到的青蒿素二聚物可直接用于疟疾、病毒、肿瘤等疾病治疗。
本发明中,
所述酯基,为羟基和羧酸、酰氯、酸酐或酯反应生成的基团,包括脂肪酸酯基和芳香酸酯基,如甲酸酯基、乙酸酯基、三氟乙酸酯基、2-甲氧基乙酸酯基、丙酸酯基、丁酸酯基、新戊酸酯基、苯甲酸酯基、对苯基苯甲酸酯基、巴豆酸酯基、4-甲氧基巴豆酸酯基等;
所述磺酸酯基,为羟基和磺酸、磺酰氯或磺酸酐反应生成的基团,包括脂肪酸酯基和芳香酸酯基,如甲磺酸酯基、三氟甲磺酸酯基、乙磺酸酯基、三氟乙磺酸酯基、对甲苯磺酸酯基、苄基磺酸酯基等;
所述卤素包括氟、氯、溴、碘。
有益效果
由于以上技术方案的实施,本发明与现有技术相比具有如下优点:
本发明方案中采用的原料例如乙二醇胺廉价易得,合成路线短、收率高、选择性好,适于大规模制备。
具体实施方式
通过下列实施例说明本发明的实施方案。然而,本发明的实施方案不受限于下列实施例中的特定细节,因为鉴于本发明的公开内容,其他变化对本领域普通技术人员是已知和显而易见的。
样品数据由以下仪器测定:核磁共振氢谱(1H-NMR)用Bruker Avance III400核磁共振仪;显色使用的精科WFH-203B三用紫外分析仪,波长为254nm和365nm。柱层析硅胶(100-200目,300-400目)为青岛海洋化工厂生产;TLC硅胶板为烟台化工厂生产的HSGF-254型薄层层析硅胶板,薄层层析使用的层析板厚度为0.2±0.03mm;3-溴-4-氟苯甲醛由山东潍坊前进精细化工有限公司提供,二乙基锌由上海恒岳化工科技有限公司提供,乙腈,甲基叔丁基醚,正庚烷,四氢呋喃均为分析纯,由国药集团化学试剂有限公司提供。所用试剂和溶剂除特别说明外,均未经特别处理。所有温度以℃(摄氏度)表示,室温或环境温度是指20~25℃,温度计未经校正。
实施例1化合物3的合成
将N-Cbz-二乙醇胺(化合物2)(1g,4.18mmol)溶于干燥二氯甲烷溶液中,然后加入双氢青蒿素(化合物1)(2.97g,10.45mmol),最后冰浴条件下滴加入三氟化硼乙醚(0.1mL,2.09mmol),然后让反应液慢慢升至室温,过夜搅拌反应基本完全。将反应液依次用水、饱和碳酸氢钠水溶液洗涤,再用水洗至中性,最后用饱和食盐水洗涤。有机相用无水硫酸钠干燥。浓缩柱分离得产物3(2.74g,产率为85%)。1H NMR(400MHz,CDCl3)δ7.45–7.29(m,5H),5.35(t,J=13.4Hz,2H),5.12(q,J=12.5Hz,2H),4.77(dd,J=17.0,3.2Hz,2H),4.08–3.94(m,2H),3.56(ddd,J=36.6,23.8,10.3Hz,6H),2.63(s,2H),2.38(td,J=13.9,3.7Hz,2H),2.04(d,J=14.2Hz,2H),1.87(s,2H),1.71(s,4H),1.59(s,2H),1.44(m,10H),1.26(dd,J=18.2,9.2Hz,6H),0.98–0.92(m,6H),0.91–0.85(m,6H).
实施例2化合物3的合成
将N-Cbz-二乙醇胺(化合物2)(1g,4.18mmol)溶于干燥二氯甲烷溶液中,然后加入双氢青蒿素衍生物(化合物4)(3.41g,10.45mmol),最后冰浴条件下滴加入三氟化硼乙醚(0.1mL,2.09mmol),然后让反应液慢慢升至室温,过夜搅拌反应基本完全。将反应液依次用水、饱和碳酸氢钠水溶液洗涤,再用水洗至中性(测定洗涤水的pH值近中性),最后用饱和食盐水洗涤。有机相用无水硫酸钠干燥。浓缩柱分离得产物3(2.27g,产率为70.4%)。1H NMR(400MHz,CDCl3)δ7.45–7.29(m,5H),5.35(t,J=13.4Hz,2H),5.12(q,J=12.5Hz,2H),4.77(dd,J=17.0,3.2Hz,2H),4.08–3.94(m,2H),3.56(ddd,J=36.6,23.8,10.3Hz,6H),2.63(s,2H),2.38(td,J=13.9,3.7Hz,2H),2.04(d,J=14.2Hz,2H),1.87(s,2H),1.71(s,4H),1.59(s,2H),1.44(m,10H),1.26(dd,J=18.2,9.2Hz,6H),0.98–0.92(m,6H),0.91–0.85(m,6H).
实施例3化合物6的合成
将2,2’-(苄基亚氨基)二乙醇胺5(120mg,1eq)、双氢青蒿素(化合物1)(400mg,2eq)溶于干燥二氯甲烷溶液中,冰浴条件下滴加TMSOTf(110mg,0.8eq),室温搅拌5h后结束反应,加入DCM,水洗,饱和食盐水洗,无水硫酸钠干燥,浓缩柱分离得产物(86mg,产率约38.5%)。1H NMR(400MHz,CDCl3)δ5.39(s,2H),4.78(d,J=3.4Hz,2H),3.95(td,J=9.4,7.8,4.6Hz,2H),3.74(t,J=9.7Hz,2H),3.49(dt,J=11.2,5.8Hz,2H),2.87–2.57(m,5H),2.47–2.31(m,2H),2.18–1.67(m,11H),1.66–1.37(m,13H),1.37–1.15(m,6H),1.04–0.83(m,14H).
实施例4化合物3的合成
将化合物6(0.1g,1eq)溶于干燥二氯甲烷溶液中,然后加入4-二甲基吡啶(8.39mg,0.5eq),冰浴条件下滴加氯甲酸苄酯(25.78mg,1.1eq)的二氯甲烷溶液,加热回流,5h后TLC显示反应完全,加DCM,水洗,饱和食盐水洗,无水硫酸钠干燥,浓缩柱分离得产物(51mg,产率约48.1%)。1H NMR(400MHz,CDCl3)δ7.45–7.29(m,5H),5.35(t,J=13.4Hz,2H),5.12(q,J=12.5Hz,2H),4.77(dd,J=17.0,3.2Hz,2H),4.08–3.94(m,2H),3.56(ddd,J=36.6,23.8,10.3Hz,6H),2.63(s,2H),2.38(td,J=13.9,3.7Hz,2H),2.04(d,J=14.2Hz,2H),1.87(s,2H),1.71(s,4H),1.59(s,2H),1.44(m,10H),1.26(dd,J=18.2,9.2Hz,6H),0.98–0.92(m,6H),0.91–0.85(m,6H).
实施例5化合物SM1044的合成
化合物SM1044的合成:将实施例1、2或4得到的产物3(0.1g)溶于THF(0.2mL)中,滴加三乙基硼氢化锂(1mL)室温搅拌过夜,次日TLC显示,原料转化约30%不再进行,浓缩,加乙酸乙酯,水洗2次,饱和食盐水洗2次,无水硫酸钠干燥,浓缩柱分离得产物(38mg,产率为46%)。1H NMR(400MHz,CDCl3)δ9.57(s,1H),6.31(s,1H),5.42(s,1H),4.85(d,J=3.5Hz,1H),4.24–4.07(m,1H),3.90–3.73(m,1H),2.78–2.59(m,1H),2.46–2.29(m,1H),2.12–1.98(m,1H),1.97–1.83(m,1H),1.80–1.57(m,3H),1.55–1.17(m,7H),1.03–0.84(m,7H).
实施例6化合物8的合成
将Fmoc保护的亚氨基二乙醇(化合物7)(1g,1eq)溶解于二氯甲烷中,加入双氢青蒿素(化合物1)(2.18g,2.5eq)后,冰浴条件下慢慢滴加三氟化硼乙醚络合物(0.5mL,0.5eq),然后让反应液慢慢升至室温,3h后TLC显示反应基本完全。加水,乙酸乙酯萃取三次,合并有机相,饱和食盐水洗2次,无水硫酸钠干燥,浓缩,柱层析得产物8(2.27g,收率86.4%)。1H NMR(400MHz,CDCl3)δ7.76(d,J=7.4Hz,2H),7.55(d,J=7.5Hz,2H),7.39(t,J=7.4Hz,2H),7.37–7.27(m,2H),5.33(d,J=18.7Hz,2H),4.71(dd,J=32.0,3.1Hz,2H),4.48–4.38(m,2H),3.95–3.78(m,2H),3.65–3.26(m,6H),2.60(d,J=4.0Hz,2H),2.35(td,J=14.0,3.7Hz,2H),2.01(d,J=14.5Hz,2H),1.85(d,J=10.9Hz,2H),1.69(d,J=9.8Hz,4H),1.55(d,J=16.1Hz,2H),1.50–1.30(m,10H),1.29–1.16(m,6H),0.90(dt,J=15.0,10.1Hz,12H).
实施例7化合物SM1044的合成
化合物SM1044的合成:将实施例6得到的产物8(1g)溶于DMF(10mL)中,加入哌啶(5mL),室温搅拌20min反应完全,加乙酸乙酯,水洗3次,饱和食盐水洗2次,无水硫酸钠干燥,浓缩得粗产物,柱分离得产物SM1044(473mg,产率为63.8%)。1H NMR(400MHz,CDCl3)δ9.57(s,1H),6.31(s,1H),5.42(s,1H),4.85(d,J=3.5Hz,1H),4.24–4.07(m,1H),3.90–3.73(m,1H),2.78–2.59(m,1H),2.46–2.29(m,1H),2.12–1.98(m,1H),1.97–1.83(m,1H),1.80–1.57(m,3H),1.55–1.17(m,7H),1.03–0.84(m,7H).
Claims (9)
2.根据权利要求1所述的制备方法,其特征在于:所述偶联试剂的用量相对于化合物(I)为0.001~1摩尔当量。
3.根据权利要求1所述的制备方法,其特征在于:
所述偶联反应的反应温度为室温,以及所述偶联反应的时间为1~12小时。
5.根据权利要求4所述的制备方法,其特征在于:所述脱保护反应在有机酸、有机碱、无机酸或无机碱存在下进行。
7.根据权利要求6所述的制备方法,其特征在于:所述结晶溶剂选自正戊烷,正己烷,正庚烷,正辛烷,环己烷,石油醚,甲苯,氯苯,甲醇,乙醇,异丙醇,正丁醇中的一种或多种;
结晶温度为-10℃~100℃。
8.根据权利要求6所述的制备方法,其中,结晶温度为-10℃~50℃。
9.根据权利要求6所述的制备方法,其中,结晶温度为0℃~20℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810191390.3A CN110240605B (zh) | 2018-03-08 | 2018-03-08 | 青蒿素二聚物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810191390.3A CN110240605B (zh) | 2018-03-08 | 2018-03-08 | 青蒿素二聚物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110240605A CN110240605A (zh) | 2019-09-17 |
CN110240605B true CN110240605B (zh) | 2021-12-31 |
Family
ID=67882645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810191390.3A Expired - Fee Related CN110240605B (zh) | 2018-03-08 | 2018-03-08 | 青蒿素二聚物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110240605B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421276A (zh) * | 2006-04-11 | 2009-04-29 | 赛诺菲-安万特 | 青蒿素衍生物的二聚物,它们的制备与它们的治疗应用 |
CN102153564A (zh) * | 2011-01-31 | 2011-08-17 | 中国科学院上海药物研究所 | 含氮原子的青蒿素二聚体、其制备方法及用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109020992B (zh) * | 2017-06-09 | 2024-04-12 | 华东理工大学 | 一种立体选择性制备β型单/双青蒿烷基醚胺马来酸盐的方法 |
-
2018
- 2018-03-08 CN CN201810191390.3A patent/CN110240605B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421276A (zh) * | 2006-04-11 | 2009-04-29 | 赛诺菲-安万特 | 青蒿素衍生物的二聚物,它们的制备与它们的治疗应用 |
CN102153564A (zh) * | 2011-01-31 | 2011-08-17 | 中国科学院上海药物研究所 | 含氮原子的青蒿素二聚体、其制备方法及用途 |
Non-Patent Citations (1)
Title |
---|
青蒿素二聚体的合成及生物活性研究进展;陈娇;《化工中间体》;20151231(第02期);第31-32页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110240605A (zh) | 2019-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7100125B2 (ja) | リボシクリブおよびその塩の改善された調製のためのプロセス | |
SU776557A3 (ru) | Способ получени оптически активных антрациклинонов | |
IL159740A (en) | A process for producing three-carbon amino-alcohol salts | |
KR102384529B1 (ko) | 4-알콕시-3-(아실 또는 알킬)옥시피콜린아미드의 제조 방법 | |
CN112125805B (zh) | 水溶性厚朴酚衍生物及和厚朴酚衍生物和其中间体的制备方法、和相关的单羟基保护中间体 | |
US10927095B2 (en) | Processes for the preparation of Niraparib and intermediates thereof | |
CN115417802A (zh) | 乌帕替尼及其中间体的制备方法 | |
CN114478690A (zh) | 一种6,6-二甲基-3-氮杂双环[3.1.0]己烷衍生物的制备方法 | |
US9771317B2 (en) | Process for preparing lacosamide and related compounds | |
CN110240605B (zh) | 青蒿素二聚物的制备方法 | |
KR101269491B1 (ko) | 엔테카비어 제조방법 | |
CN110790689A (zh) | 一种1,1-二氟-2-异腈-乙基苯基砜类化合物的合成方法 | |
WO2018015929A1 (en) | A novel process for the preparation of hiv protease inhibitor and intermediates thereof | |
CN112920053A (zh) | 一种手性α-甲基芳乙胺的制备方法 | |
WO2019008595A1 (en) | PROCESS FOR THE PREPARATION OF 1- (4-FLUOROBENZYL) -3- (4-ISOBUTOXYBENZYL) -1- (1-METHYLPIPERIDIN-4-YL) UREA AND ITS SALTS | |
JP6528251B2 (ja) | (s)−1−((2r,3r,4s,5s)−5−アリル−3−メトキシ−4−(トシルメチル)テトラヒドロフラン−2−イル)−3−アミノプロパン−2−オールの結晶性誘導体 | |
CN116082361B (zh) | 一种制备玛巴洛沙韦中间体和玛巴洛沙韦的方法 | |
JP2013508397A (ja) | 高分子化合物の調製方法 | |
CN108101881B (zh) | 用于制备曲贝替定的方法及其中间体 | |
WO2022194022A1 (zh) | 一种纳布啡癸二酸酯及其中间体的制备方法 | |
CN115385932A (zh) | 吡啶酮衍生物的中间体及其制备方法 | |
CN111479800A (zh) | 一种中间体化合物及其制备方法,及以该中间体化合物制备多肽的固相合成方法 | |
KR100488393B1 (ko) | 2-아자비사이클로[2.2.1]헵탄유도체,이의제조방법및사용방법 | |
CN117924154A (zh) | 一种哌啶-2-甲酸酯类化合物的制备方法 | |
WO2022202814A1 (ja) | ピリミジン化合物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211231 |
|
CF01 | Termination of patent right due to non-payment of annual fee |